Effect of Alogliptin Combined with Pioglitazone on β-Cell Function and Insulin Resistance in Metformin-Treated Patients with Type 2 Diabetes

被引：0
|
作者：
Defronzo, Ralph A.
Burant, Charles F.
Fleck, Penny
Wilson, Craig
Mekki, Qais
Pratley, Richard
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A519 / A519
页数：1
相关论文
共 50 条
  • [21] The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy
    Tai, He
    Wang, Ming-Yue
    Zhao, Yue-Ping
    Li, Ling-Bing
    Dong, Qian-Yan
    Liu, Xin-Guang
    Kuang, Jin-Song
    MEDICINE, 2016, 95 (33)
  • [22] Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes
    R. Basu
    A. Basu
    V. Chandramouli
    B. Norby
    B. Dicke
    P. Shah
    O. Cohen
    B. R. Landau
    R. A. Rizza
    Diabetologia, 2008, 51 : 2031 - 2040
  • [23] Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes
    Basu, R.
    Basu, A.
    Chandramouli, V.
    Norby, B.
    Dicke, B.
    Shah, P.
    Cohen, O.
    Landau, B. R.
    Rizza, R. A.
    DIABETOLOGIA, 2008, 51 (11) : 2031 - 2040
  • [24] Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated diabetic patients
    Kopecky, J.
    Veleba, J.
    Janovska, P.
    Kuda, O.
    Horakova, O.
    Malinska, H.
    Kazdova, L.
    Olza, J.
    Calder, P.
    Gardlo, A.
    Fiserova, E.
    Jensen, J.
    Bryhn, M.
    Kopecky, J., Sr.
    Pelikanova, T.
    DIABETOLOGIA, 2015, 58 : S342 - S343
  • [25] Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism
    Jiri Veleba
    Jan Kopecky
    Petra Janovska
    Ondrej Kuda
    Olga Horakova
    Hana Malinska
    Ludmila Kazdova
    Olena Oliyarnyk
    Vojtech Skop
    Jaroslava Trnovska
    Milan Hajek
    Antonin Skoch
    Pavel Flachs
    Kristina Bardova
    Martin Rossmeisl
    Josune Olza
    Gabriela Salim de Castro
    Philip C. Calder
    Alzbeta Gardlo
    Eva Fiserova
    Jørgen Jensen
    Morten Bryhn
    Jan Kopecky
    Terezie Pelikanova
    Nutrition & Metabolism, 12
  • [26] Discontinuation of metformin in type 2 diabetes patients treated with insulin
    Wulffelé, MG
    Kooy, A
    Lehert, P
    Bets, D
    Oom, JA
    van der Burg, BB
    Donker, AJM
    Stehouwer, CDA
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (06): : 249 - 252
  • [27] Adherence to Clinic Visits Is Not Improved by Insulin Use in Metformin-treated Children and Teens with Type 2 Diabetes
    Hansen, David W.
    Rein, Lisa E.
    Cabrera, Susanne M.
    DIABETES, 2015, 64 : A363 - A363
  • [28] The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin
    Tooke, JE
    Elston, LM
    Gooding, KM
    Ball, CI
    Mawson, DM
    Piper, J
    Sriraman, R
    Urquhart, R
    Shore, AC
    DIABETOLOGIA, 2006, 49 (05) : 1064 - 1070
  • [29] The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin
    J. E. Tooke
    L. M. Elston
    K. M. Gooding
    C. I. Ball
    D. M. Mawson
    J. Piper
    R. Sriraman
    R. Urquhart
    A. C. Shore
    Diabetologia, 2006, 49
  • [30] Efficacy and Safety of Alogliptin Combined with Pioglitazone in Patients with Type 2 Diabetes Inadequately Controlled with Diet and Exercise
    Rosenstock, Julio
    Inzucchi, Silvio
    Seufert, Jochen
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2009, 58 : A523 - A523
12345